Graph Neural Network-enabled Terahertz-based Flow-guided Nanoscale Localization

Scientific advancements in nanotechnology and advanced materials are paving the way toward nanoscale devices for in-body precision medicine; comprising integrated sensing, computing, communication, data and energy storage capabilities. In the human cardiovascular system, such devices are envisioned to be passively flowing and continuously sensing for detecting events of diagnostic interest. The diagnostic value of detecting such events can be enhanced by assigning to them their physical locations (e.g., body region), which is the main proposition of flow-guided localization. Current flow-guided localization approaches suffer from low localization accuracy and they are by-design unable to localize events within the entire cardiovascular system. Toward addressing this issue, we propose the utilization of Graph Neural Networks (GNNs) for this purpose, and demonstrate localization accuracy and coverage enhancements of our proposal over the existing State of the Art (SotA) approaches. Based on our evaluation, we provide several design guidelines for GNN-enabled flow-guided localization.Comment: 6 pages, 5 figures, 1 table, 15 references. arXiv admin note: text overlap with arXiv:2305.1849

Insights from the Design Space Exploration of Flow-Guided Nanoscale Localization

Nanodevices with Terahertz (THz)-based wireless communication capabilities are providing a primer for flow-guided localization within the human bloodstreams. Such localization is allowing for assigning the locations of sensed events with the events themselves, providing benefits in precision medicine along the lines of early and precise diagnostics, and reduced costs and invasiveness. Flow-guided localization is still in a rudimentary phase, with only a handful of works targeting the problem. Nonetheless, the performance assessments of the proposed solutions are already carried out in a non-standardized way, usually along a single performance metric, and ignoring various aspects that are relevant at such a scale (e.g., nanodevices' limited energy) and for such a challenging environment (e.g., extreme attenuation of in-body THz propagation). As such, these assessments feature low levels of realism and cannot be compared in an objective way. Toward addressing this issue, we account for the environmental and scale-related peculiarities of the scenario and assess the performance of two state-of-the-art flow-guided localization approaches along a set of heterogeneous performance metrics such as the accuracy and reliability of localization.Comment: 6 pages, 4 figures, 2 table

Toward Standardized Performance Evaluation of Flow-guided Nanoscale Localization

Nanoscale devices featuring Terahertz (THz)-based wireless communication capabilities are envisioned to be deployed within human bloodstreams. Such devices are envisaged to enable fine-grained sensing-based applications for detecting events for early indications of various health conditions, as well as actuation-based ones such as the targeted drug delivery. Intuitively, associating the locations of such events with the events themselves would provide an additional utility for precision diagnostics and treatment. This vision recently yielded a new class of in-body localization coined under the term "flow-guided nanoscale localization". Such localization can be piggybacked on THz-based communication for detecting body regions in which events were observed based on the duration of one circulation of a nanodevice in the bloodstream. From a decades-long research on objective benchmarking of "traditional" indoor localization, as well as its eventual standardization (e.g., ISO/IEC 18305:2016), we know that in early stages the reported performance results were often incomplete (e.g., targeting a subset of relevant metrics), carrying out benchmarking experiments in different evaluation environments and scenarios, and utilizing inconsistent performance indicators. To avoid such a "lock-in" in flow-guided localization, in this paper we discuss a workflow for standardized evaluation of such localization. The workflow is implemented in the form of an open-source framework that is able to jointly account for the mobility of the nanodevices in the bloodstream, in-body THz communication between the nanodevices and on-body anchors, and energy-related and other technological constraints at the nanodevice level. Accounting for these constraints, the framework is able to generate the raw data that can be streamlined into different flow-guided solutions for generating standardized performance benchmarks.Comment: 8 pages, 6 figures, 15 references, available at: https://bitbucket.org/filip_lemic/flow-guided-localization-in-ns3/src/master

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity